Loveday and colleagues [74] identified truncating RAD51D mutations in 8 of 911 familial breast-ovarian cancer pedigrees, demonstrating that RAD51D mutations confer a sixfold increased risk of ovarian cancer but cause only a small increase in breast cancer. Here, RAD51D is linked to breast carcinoma.